Skip to main content

Tolerance Mechanisms in the Late Phase of the Antibody Response

  • Conference paper
Mechanisms of Lymphocyte Activation and Immune Regulation XI

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 596))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Liston, A., S. Lesage, J. Wilson, L. Peltonen, and C.C. Goodnow. 2003. Aire regulates negative selection of organ-specific T cells. Nat Immunol 4:350–354.

    Article  PubMed  CAS  Google Scholar 

  2. Liston, A., D.H. Gray, S. Lesage, A.L. Fletcher, J. Wilson, K.E. Webster, H.S. Scott, R.L. Boyd, L. Peltonen, and C.C. Goodnow. 2004. Gene dosage–limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J Exp Med 200:1015–1026.

    Article  PubMed  CAS  Google Scholar 

  3. Khattri, R., T. Cox, S.A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337–342.

    Article  PubMed  CAS  Google Scholar 

  4. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336.

    Article  PubMed  CAS  Google Scholar 

  5. Schwartz, R.H. 2003. T Cell Anergy. Annu Rev Immunol 21:305–334.

    Article  PubMed  CAS  Google Scholar 

  6. Goodnow, C.C., J. Sprent, B.F. de St Groth, and C.G. Vinuesa. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435:590–597.

    Article  PubMed  CAS  Google Scholar 

  7. Rieux-Laucat, F., F. Le Deist, C. Hivroz, A. Roberts, K. Debatin, A. Fischer, and J. de Villartay. 1995. Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity. Science 268:1347–1349.

    Article  PubMed  CAS  Google Scholar 

  8. Lenardo, M., K.M. Chan, F. Hornung, H. McFarland, R. Siegel, J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis – immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 17:221–253.

    Article  PubMed  CAS  Google Scholar 

  9. MacLennan, I.C. 1994. Germinal centers. Annu Rev Immunol 12:117–139.

    Article  PubMed  CAS  Google Scholar 

  10. Radic, M.Z., and M. Weigert. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12:487–520.

    Article  PubMed  CAS  Google Scholar 

  11. Cappione, A.J., A.E. Pugh-Bernard, J.H. Anolik, and I. Sanz. 2004. Lupus IgG VH4.34 antibodies bind to a 220-kDa glycoform of CD45/B220 on the surface of human B lymphocytes. J Immunol 172:4298–4307.

    PubMed  CAS  Google Scholar 

  12. Pugh-Bernard, A.E., G.J. Silverman, A.J. Cappione, M.E. Villano, D.H. Ryan, R.A. Insel, and I. Sanz. 2001. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest 108:1061–1070.

    Article  PubMed  CAS  Google Scholar 

  13. Cappione, A., J.H. Anolik, A. Pugh-Bernard, J. Barnard, P. Dutcher, G. Silverman, and I. Sanz. 2005. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest 115:3205–3216.

    Article  PubMed  CAS  Google Scholar 

  14. Shokat, K.M., and C.C. Goodnow. 1995. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375:334–338.

    Article  PubMed  CAS  Google Scholar 

  15. Pulendran, B., G. Kannourakis, S. Nouri, K.G. Smith, and G.J. Nossal. 1995. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375:331–334.

    Article  PubMed  CAS  Google Scholar 

  16. Vinuesa, C.G., M.C. Cook, C. Angelucci, V. Athanasopoulos, L. Rui, K.M. Hill, D. Yu, H. Domashenz, B. Whittle, T. Lambe, I.S. Roberts, R.R. Copley, J.I. Bell, R.J. Cornall, and C.C. Goodnow. 2005. A novel RING-type ubiquitin ligase family member essential to repress follicular helper T cells and autoimmunity. Nature 435:452–458.

    Article  PubMed  CAS  Google Scholar 

  17. Nelms, K.A., and C.C. Goodnow. 2001. Genome-wide ENU mutagenesis to reveal immune regulators. Immunity 15:409–418.

    Article  PubMed  CAS  Google Scholar 

  18. Vinuesa, C.G., and C.C. Goodnow. 2004. Illuminating autoimmune regulators through controlled variation of the mouse genome sequence. Immunity 20:669–679.

    Article  PubMed  CAS  Google Scholar 

  19. Hutloff, A., A.M. Dittrich, K.C. Beier, B. Eljaschewitsch, R. Kraft, I. Anagnostopoulos, and R.A. Kroczek. 1999. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397:263–266.

    Article  PubMed  CAS  Google Scholar 

  20. Grimbacher, B., A. Hutloff, M. Schlesier, E. Glocker, K. Warnatz, R. Drager, H. Eibel, B. Fischer, A.A. Schaffer, H.W. Mages, R.A. Kroczek, and H.H. Peter. 2003. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4:261–268.

    Article  PubMed  CAS  Google Scholar 

  21. McAdam, A.J., R.J. Greenwald, M.A. Levin, T. Chernova, N. Malenkovich, V. Ling, G.J. Freeman, and A.H. Sharpe. 2001. ICOS is critical for CD40-mediated antibody class switching. Nature 409:102–105.

    Article  PubMed  CAS  Google Scholar 

  22. . Scott, B.G., H. Yang, E. Tuzun, C. Dong, R.A. Flavell, and P. Christadoss. 2004. ICOS is essential for the development of experimental autoimmune myasthenia gravis. J Neuroimmunol 153:16–25.

    Article  PubMed  CAS  Google Scholar 

  23. Tafuri, A., A. Shahinian, F. Bladt, S.K. Yoshinaga, M. Jordana, A. Wakeham, L.M. Boucher, D. Bouchard, V.S. Chan, G. Duncan, B. Odermatt, A. Ho, A. Itie, T. Horan, J.S. Whoriskey, T. Pawson, J.M. Penninger, P.S. Ohashi, and T.W. Mak. 2001. ICOS is essential for effective T-helper-cell responses. Nature 409:105–109.

    Article  PubMed  CAS  Google Scholar 

  24. Dong, C., A.E. Juedes, U.A. Temann, S. Shresta, J.P. Allison, N.H. Ruddle, and R.A. Flavell. 2001. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409:97–101.

    Article  PubMed  CAS  Google Scholar 

  25. Calame, K.L., K.I. Lin, and C. Tunyaplin. 2003. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol 21:205–230.

    Article  PubMed  CAS  Google Scholar 

  26. Rui, L., C.G. Vinuesa, J. Blasioli, and C.C. Goodnow. 2003. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat Immunol 4:594–600.

    Article  PubMed  Google Scholar 

  27. Healy, J.I., R.E. Dolmetsch, L.A. Timmerman, J.G. Cyster, M.L. Thomas, G.R. Crabtree, R.S. Lewis, and C.C. Goodnow. 1997. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. Immunity 6:419–428.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this paper

Cite this paper

Goodnow, C.C., Campbell, J.A., Rui, L., Vinuesa, C.G. (2007). Tolerance Mechanisms in the Late Phase of the Antibody Response. In: Gupta, S., Alt, F., Cooper, M., Melchers, F., Rajewsky, K. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation XI. Advances in Experimental Medicine and Biology, vol 596. Springer, Boston, MA. https://doi.org/10.1007/0-387-46530-8_15

Download citation

Publish with us

Policies and ethics